Cargando…

Pioneering Studies of the “Morning-After” Pill

Yale School of Medicine produced the first proof-of-concept study on the viability of a “morning-after” pill for human use. This study was a result of a fruitful collaboration between a pair of Yale scientists, Drs. John M. Morris and Gertrude van Wagenen, who sought a non-abortion, post-coital cont...

Descripción completa

Detalles Bibliográficos
Autor principal: Kunjappu, Mary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117403/
https://www.ncbi.nlm.nih.gov/pubmed/21698041
_version_ 1782206329054560256
author Kunjappu, Mary J.
author_facet Kunjappu, Mary J.
author_sort Kunjappu, Mary J.
collection PubMed
description Yale School of Medicine produced the first proof-of-concept study on the viability of a “morning-after” pill for human use. This study was a result of a fruitful collaboration between a pair of Yale scientists, Drs. John M. Morris and Gertrude van Wagenen, who sought a non-abortion, post-coital contraceptive. They tested a variety of hormones, hormone-based synthetic drugs, and other compounds in monkeys in an effort to uncover a compound that was non-toxic but highly effective. Unfortunately, although they were unable to identify such a drug, their initial studies inspired other scientists to further pursue the concept of a “morning-after” pill, leading to the development of Food and Drug Administration (FDA)-approved emergency contraceptives.
format Online
Article
Text
id pubmed-3117403
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher YJBM
record_format MEDLINE/PubMed
spelling pubmed-31174032011-06-22 Pioneering Studies of the “Morning-After” Pill Kunjappu, Mary J. Yale J Biol Med Focus: Yale School of Medicine Bicentennial Yale School of Medicine produced the first proof-of-concept study on the viability of a “morning-after” pill for human use. This study was a result of a fruitful collaboration between a pair of Yale scientists, Drs. John M. Morris and Gertrude van Wagenen, who sought a non-abortion, post-coital contraceptive. They tested a variety of hormones, hormone-based synthetic drugs, and other compounds in monkeys in an effort to uncover a compound that was non-toxic but highly effective. Unfortunately, although they were unable to identify such a drug, their initial studies inspired other scientists to further pursue the concept of a “morning-after” pill, leading to the development of Food and Drug Administration (FDA)-approved emergency contraceptives. YJBM 2011-06 2011-06 /pmc/articles/PMC3117403/ /pubmed/21698041 Text en Copyright ©2011, Yale Journal of Biology and Medicine https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons CC BY-NC license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use the material for commercial purposes.
spellingShingle Focus: Yale School of Medicine Bicentennial
Kunjappu, Mary J.
Pioneering Studies of the “Morning-After” Pill
title Pioneering Studies of the “Morning-After” Pill
title_full Pioneering Studies of the “Morning-After” Pill
title_fullStr Pioneering Studies of the “Morning-After” Pill
title_full_unstemmed Pioneering Studies of the “Morning-After” Pill
title_short Pioneering Studies of the “Morning-After” Pill
title_sort pioneering studies of the “morning-after” pill
topic Focus: Yale School of Medicine Bicentennial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117403/
https://www.ncbi.nlm.nih.gov/pubmed/21698041
work_keys_str_mv AT kunjappumaryj pioneeringstudiesofthemorningafterpill